Price $12.96 |
Market Cap
534.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.31
|
P/S
1.69
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-23K
|
FCF
-0.6
|
|
Op. Margin
-10.50%
|
Net Margin
-10.20%
|
ROE
-7.70%
|
ROI
-5.60%
|
|
ROA
-5.90%
|
EPS Growth
6.50%
|
Current Ratio
1.9
|
Debt/Equity
5.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| OraSure Technologies, Inc. (OSUR) | $5.33 | - | - | 348.6M | Strong Buy |
| Ligand Pharmaceuticals Inc (LGND) | $68.16 | - | - | 1.14B | Strong Buy |
| Avalo Therapeutics Inc (AVTX) | $3.90 | - | - | 47.6M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.94 | - | - | 106.2M | Strong Buy |
| Societal CDMO Inc (SCTL) | $1.32 | - | - | 120.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
